CLINICAL_TRIALS trial_result · 2021-08-06

Clinical Trial Update: rVWF IN PROPHYLAXIS [Phase 3]

Summary

Phase 3 clinical trial update for recombinant von Willebrand factor (rVWF) used for prophylaxis in von Willebrand disease; trial completed with posted results i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Takeda | Conditions: Von Willebrand Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-08-06